EVOQ Therapeutics

#Autoimmune disease #EVOQ Therapeutics #Funding #National Institutes of Health (NIH)

$2 million in funding for autoimmune nanodisc therapies

EVOQ Therapeutics has received a $2 million grant from the National Institutes of Health (NIH) to advance novel therapies for autoimmune diseases. Dr James Moon, Chief Scientific Officer of EVOQ Therapeutics, said: "This support will enable us to accelerate the development of our platform, which we believe could offer significant… Read More

#Business & Investment #News